Crystal structure of rhodopsin: implications for vision and beyond

被引:114
作者
Okada, T [1 ]
Palczewski, K
机构
[1] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto 6068502, Japan
[2] Univ Washington, Dept Ophthalmol, Seattle, WA 98105 USA
关键词
D O I
10.1016/S0959-440X(00)00227-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A heptahelical transmembrane bundle is a common structural feature of G-protein-coupled receptors (GPCRs) and bacterial retinal-binding proteins, two functionally distinct groups of membrane proteins. Rhodopsin, a photoreceptor protein involved in photopic (rod) vision, is a prototypical GPCR that contains 11-cis-retinal as its intrinsic chromophore ligand. Therefore, uniquely, rhodopsin is a GPCR and also a retinal-binding protein, but is not found in bacteria. Rhodopsin functions as a typical GPCR in processes that are triggered by light and photoisomerization of its ligand. Bacteriorhodopsin is a light-driven proton pump with an all-trans-retinal chromophore that photoisomerizes to 13-cis-retinal. The recent crystal structure determination of bovine rhodopsin revealed a structure that is not similar to previously established bacteriorhodopsin structures. Both groups of proteins have a heptahelical transmembrane bundle structure, but the helices are arranged differently. The activation of rhodopsin involves rapid cis-trans photoisomerization of the chromophore, followed by slower and incompletely defined structural rearrangements. For rhodopsin and related receptors, a common mechanism is predicted for the formation of an active state intermediate that is capable of interacting with G proteins.
引用
收藏
页码:420 / 426
页数:7
相关论文
共 53 条
[41]   Characteristics for a salt-bridge switch mutation of the α1b adrenergic receptor -: Altered pharmacology and rescue of constitutive activity [J].
Porter, JE ;
Perez, DM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (49) :34535-34538
[42]   Mutation of a highly conserved aspartic acid in the β2 adrenergic receptor:: Constitutive activation, structural instability, and conformational rearrangement of transmembrane segment 6 [J].
Rasmussen, SGF ;
Jensen, AD ;
Liapakis, G ;
Ghanouni, P ;
Javitch, JA ;
Gether, U .
MOLECULAR PHARMACOLOGY, 1999, 56 (01) :175-184
[43]   CONSTITUTIVELY ACTIVE MUTANTS OF RHODOPSIN [J].
ROBINSON, PR ;
COHEN, GB ;
ZHUKOVSKY, EA ;
OPRIAN, DD .
NEURON, 1992, 9 (04) :719-725
[44]   Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F [J].
Sheikh, SP ;
Zvyaga, TA ;
Lichtarge, O ;
Sakmar, TP ;
Bourne, HR .
NATURE, 1996, 383 (6598) :347-350
[45]   Retinylidene proteins: Structures and functions from archaea to humans [J].
Spudich, JL ;
Yang, CS ;
Jung, KH ;
Spudich, EN .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2000, 16 :365-+
[46]  
STRADER CD, 1991, J BIOL CHEM, V266, P5
[47]   Molecular mechanism of vectorial proton translocation by bacteriorhodopsin [J].
Subramaniam, S ;
Henderson, R .
NATURE, 2000, 406 (6796) :653-657
[48]   The structure of bacteriorhodopsin: an emerging consensus [J].
Subramaniam, S .
CURRENT OPINION IN STRUCTURAL BIOLOGY, 1999, 9 (04) :462-468
[49]   Constitutive activation of G protein-coupled receptors as a result of selective substitution of a conserved leucine residue in transmembrane helix III [J].
Tao, YX ;
Abell, AN ;
Liu, XB ;
Nakamura, K ;
Segaloff, DL .
MOLECULAR ENDOCRINOLOGY, 2000, 14 (08) :1272-1282
[50]   Advances in determination of a high-resolution three-dimensional structure of rhodopsin, a model of G-protein-coupled receptors (GPCRs) [J].
Teller, DC ;
Okada, T ;
Behnke, CA ;
Palczewski, K ;
Stenkamp, RE .
BIOCHEMISTRY, 2001, 40 (26) :7761-7772